<DOC>
	<DOC>NCT00302770</DOC>
	<brief_summary>This trial will explore the efficacy of quetiapine in Social Anxiety Disorder, generalized type. The following elements of response will be tested: number of responders to treatment, time to response, effect size as measured with the LSAS</brief_summary>
	<brief_title>Efficacy of Quetiapine in Generalised Social Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Written Confirmed Consent, All patients meet the DSM IV criteria for generalized social anxiety disorder, A score â‰¥ 60 on the LSAS, male and female aged between 18 and 65 years Presence of any primary axis I diagnosis other than social anxiety disorder according to DSMIV, alcohol and/or substance abuse according to DSMIV criteria within the last 12 months, any personality disorder as the primary diagnosis, with the exception of avoidant personality disorder, patients at risk of suicide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Patients with SAD</keyword>
</DOC>